• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED

4.00% ! 1.2¢
Market Cap $110.5M  !

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH 19:29 110 12K
19:29 Last post  shlok Comments Created with Sketch.  110  Views Created with Sketch.  12K 
ATH 17:54 120 28K
17:54 Last post  shlok Comments Created with Sketch.  120  Views Created with Sketch.  28K 
ATH
News, articles and interviews
3 4 5
10:12 290 107K
TRENDING NEWS

Two '4D' stocks to watch, but only one winner

NEWS
11 Sep 2025
10:12 Last post  ralphs Comments Created with Sketch.  290  Views Created with Sketch.  107K 
ATH 10/09/25 174 33K
10/09/25 Last post  Scottbm Comments Created with Sketch.  174  Views Created with Sketch.  33K 
ATH
7news Melbourne - 7plus
10/09/25 4 1.5K
10/09/25 Last post  420247 Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
ATH
Stock price - ATH/ATHE
41 42 43
10/09/25 2.5K 839K
10/09/25 Last post  420247 Comments Created with Sketch.  2.5K  Views Created with Sketch.  839K 
ATH 08/09/25 0 267
08/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  267 
ATH
Future drug compounds
07/09/25 16 3.5K
07/09/25 Last post  pivalde Comments Created with Sketch.  16  Views Created with Sketch.  3.5K 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - ATH
08 Sep 09:47
 
Alterity Raises A$20.0 million in Strategic Placement
08 Sep 09:47
 
Trading Halt
04 Sep 09:09
 
Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC
02 Sep 11:17
 
Alterity Therapeutics to Present at the Biotech Showcase
01 Sep 10:06
 
Corporate Governance Statement
29 Aug 10:17
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.2¢
Change
-0.001(4.00%)
Mkt cap ! $110.5M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $28.98K 2.408M

Buyers (Bids)

No. Vol. Price($)
36 15772214 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 8854744 13
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
Last
1.3¢
  Change
-0.001 ( 4.17 %)
Open High Low Volume
1.2¢ 1.3¢ 1.2¢ 7914134
Last updated 15.59pm 11/09/2025 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.